Table 3.
Straina | Mutation |
CIP MIC (μg/ml)b | |||||||
---|---|---|---|---|---|---|---|---|---|
parC | gyrA | spr0129 | spr0335 | spr1544 | spr1902 | patA | patB | ||
R6 | WT | WT | WT | WT | WT | WT | WT | WT | 0.5 |
R6smR | WT | WT | WT | WT | WT | WT | WT | WT | 0.5 |
R6spr1902-T5R6M2B, smR | WT | WT | WT | WT | WT | T5-R6M2B | WT | WT | 0.5 |
R6parC-R6M2B | R6M2B | WT | WT | WT | WT | WT | WT | WT | 2 |
R6parC,spr1902-T5R6M2B, smR | R6M2B | WT | WT | WT | WT | T5-R6M2B | WT | WT | 2 |
R6parC,gyrA-R6M2B | R6M2B | R6M2B | WT | WT | WT | WT | WT | WT | 32 |
R6parC,gyrA,spr1544-T5R6M2B,smR | R6M2B | R6M2B | WT | WT | T5-R6M2B | WT | WT | WT | 32 |
R6parC,gyrA,spr1902-T5R6M2B,smR | R6M2B | R6M2B | WT | WT | WT | T5-R6M2B | WT | WT | 64 |
R6patA,T1-60827,smR | WT | WT | WT | WT | WT | WT | T1-60827 | WT | 1 |
R6patB,T1-60827,smR | WT | WT | WT | WT | WT | WT | WT | T1-60827 | 1 |
T1-60827 | WT | WT | WT | WT | WT | WT | T1-60827 | T1-60827 | 2 |
T5-R6M2B | R6M2B | R6M2B | WT | T5-R6M2B | T5-R6M2B | T5-R6M2B | WT | WT | 128 |
T5-R6M2Bspr0335R6,smR | R6M2B | R6M2B | WT | WT | R6M2B | R6M2B | WT | WT | 64 |
R6M2B | R6M2B | R6M2B | R6M2B | WT | WT | WT | WT | WT | 128 |
R6M2Bspr0129R6,smR | R6M2B | R6M2B | WT | WT | WT | WT | WT | WT | 128 |
“smR” indicates that an rpsL+ allele conferring resistance to streptomycin was cotransformed along with the PCR fragment of interest for selection purposes. These strains are resistant to streptomycin.
MICs in bold are significantly different from the parent strain without the mutation.